The IL-33/ST2 pathway plays a crucial role in neurodegenerative diseases and is activated by tissue injury, fibrosis, remodeling, and inflammation; moreover, the pathway participates in the homeostasis or pathogenic mechanisms of such disorders. Here, IL33 is linked to neurodegenerative disease.